MAPT and Alzheimer disease: Since then, this dye has attracted increasing interest because of its use as a therapy to improve cognitive functions in AD patients [11,60,61], based on the fact that the formation of tau aggregates is involved in its toxicity and that inhibition of tau aggregation by MB may be linked to a reduction or loss of toxicity [62].